CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 30 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $398,000 | -55.0% | 188,799 | -38.3% | 0.00% | – |
| Q1 2021 | $884,000 | +67.4% | 306,066 | +24.0% | 0.00% | – |
| Q4 2020 | $528,000 | -63.0% | 246,849 | +7.1% | 0.00% | – |
| Q3 2020 | $1,427,000 | -3.3% | 230,579 | +0.4% | 0.00% | – |
| Q2 2020 | $1,476,000 | +236.2% | 229,601 | +117.0% | 0.00% | – |
| Q1 2020 | $439,000 | -53.9% | 105,788 | -34.3% | 0.00% | – |
| Q4 2019 | $952,000 | +120.9% | 161,086 | +101.8% | 0.00% | – |
| Q3 2019 | $431,000 | -33.1% | 79,825 | 0.0% | 0.00% | – |
| Q2 2019 | $644,000 | +3.9% | 79,825 | +1.9% | 0.00% | – |
| Q1 2019 | $620,000 | +146.0% | 78,363 | +34.9% | 0.00% | – |
| Q4 2018 | $252,000 | – | 58,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |